Bone Drugs May Raise Risk for Eye Pain (CME/CE)

by MedPage Today • 2012/04/03 • 0 Comments

(MedPage Today) -- Oral bisphosphonate therapy may boost the risk of inflammatory eye complications in first-time users versus nonusers, researchers found.

Full Story →

← Avedro, ACOS commence accelerated corneal cross-linking Phase 3 study

Two phase III studies evaluate the use of combination verteporfin photodynamic therapy with ranibizumab for subfoveal choroidal neovascularisation secondary to AMD →

Post navigation